The CNS effects of Ginkgo biloba extracts and ginkgolide B

Progress in Neurobiology

Volumn 67, Issue 3, 2002, Pages 235-257

  Maclennan, Karyn M ^a   Darlington, Cynthia L ^a   Smith, Paul F ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; GINKGO BILOBA EXTRACT; GINKGOLIDE B; NEUROPEPTIDE; NEUROPROTECTIVE AGENT; PLANT EXTRACT; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

ANTIOXIDANT ACTIVITY; ANXIETY NEUROSIS; APOPTOSIS; ASTHENIA; BLEEDING; BRAIN BLOOD FLOW; BRAIN DYSFUNCTION; BRAIN INJURY; BRAIN ISCHEMIA; CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR ACCIDENT; CHEMICAL COMPOSITION; CLINICAL TRIAL; COGNITION; COMA; DEMENTIA; DISEASE SEVERITY; DROWSINESS; DRUG METABOLISM; ENCEPHALITIS; GASTROINTESTINAL DISEASE; GINKGO BILOBA; HEADACHE; HICCUP; HUMAN; LONG TERM POTENTIATION; MEDICINAL PLANT; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RETINA DEGENERATION; REVIEW; SIGNAL TRANSDUCTION; SKIN ALLERGY; SUBARACHNOID HEMORRHAGE; SUBDURAL HEMATOMA; VESTIBULAR DISORDER;

BRAIN; BRAIN DISEASES; DITERPENES; FREE RADICAL SCAVENGERS; GINKGO BILOBA; GINKGOLIDES; LACTONES; NEUROPROTECTIVE AGENTS; PLANT EXTRACTS;

EID: 0036343060     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(02)00015-1     Document Type: Review

References (200)

1. Inhibition of serum deprivation- and staurosporine-induced neuronal apoptosis by Ginkgo biloba extract and some of its constituents
2. Platelet-activating factor is an important mediator in hypoxic ischemic brain injury in the newborn rat
3. The effect of meclofenoxate with Ginkgo biloba extract or zinc on lipid peroxide, some free radical scavengers and the cardiovascular system of aged rats
4. In vivo regulation of peripheral-type benzodiazepine receptor and glucocorticoid synthesis by Ginkgo biloba extract EGb-761 and isolated ginkgolides
5. Ex vivo regulation of adrenal cortical cell steroid and protein synthesis, in response to adrenocorticotropic hormone stimulation, by the Ginkgo biloba extract EGb-761 and isolated ginkgolide B
6. Ginkgo biloba extract facilitates recovery from penetrating brain injury in adult male rats
7. Immunoregulatory functions of PAF-acether. IX. Modulation of apoptosis in an immature T cell line
8. The potential for platelet-activating factor synthesis in brain: Properties of cholinephosphotransferase and 1-alkyl-sn-glycero-3-phosphate acetyltransferase in microsomal fractions of immature rabbit cerebral cortex
9. Effect of long-term treatment with EGb-761 on age-dependent structural changes in the hippocampi of three inbred mouse strains
10. The Ginkgo biloba extract (EGb-761) protects and rescues hippocampal cells against nitric oxide-induced toxicity: Involvement of its flavonoid constituents and protein kinase C
11. The Ginkgo biloba extract (EGb-761) protects hippocampal neurons against cell death induced by b-amyloid
12. Inhibition of preretinal proliferation by free radical scavengers in an experimental model of tractional retinal detachment
13. Peroxynitrite cytotoxicity on bovine retinal pigmented epithelial cells in culture
14. Leukocyte-dependent histamine release from rabbit platelet: The role of IgE basophils and a platelet-activating factor
15. The alkyl-ether phospholipid platelet-activating factor is a stimulator of the hypothalamic-pituitary-adrenal axis in the rat
16. Bioavailability of ginkgolides and bilobalide from extracts of Ginkgo biloba using GC/MS
17. Platelet-activating factor antagonist BN52021 decreases accumulation of free polyunsaturated fatty acid in mouse brain during ischemia and electroconvulsive shock
18. 2+ in hippocampal neurons
19. Effect of platelet-activating factor on hypothalamic and hypophyseal pro-opiomelanocortin-related peptides and hypothalamo-pituitary-adrenal axis in the rat
20. A synaptic model of memory: Long-term potentiation in the hippocampus
21. Stress-induced 5-HT1A receptor desensitization: Protective effects of Ginkgo biloba extract (EGb-761)
22. Platelet-activating factor and the cytokine network in inflammatory processes
23. Motor function in young and aged hemiplegic rats: Effects of a Ginkgo biloba extract
24. Acceleration of functional recovery from motor cortex ablation by two Ginkgo biloba extracts in rats
25. The ginkgolides: Potent platelet-activating factor antagonists isolated from Ginkgo biloba L.: Chemistry, pharmacology and clinical applications
26. Perspectives in platelet-activating factor research
27. Platelet-activating factor receptor blockade decreases early post-traumatic cerebral edema in rats
28. Platelet-activating factor: Receptors and signal transduction
29. Possible existence of two subsets of platelet-activating factor receptor to mediate polyphosphoinositide breakdown and calcium influx in neuroblastoma × glioma hybrid NG 108-15 cells
30. Different effects of the constituents of EGb-761 on apoptosis in rat cerebellar granule cells induced by hydroxyl radicals
31. Interactions of Ginkgo biloba extract (EGb-761), diazepam and ethyl b-carboline-3-carboxylate on social behavior of the rat
32. Enhancement of hippocampal excitatory synaptic transmission by platelet-activating factor
33. Effects of Ginkgo biloba extract (EGb-761) on learning and possible actions on aging
34. Therapeutic value of Ginkgo biloba in reducing symptoms of decline in mental function
35. Effects of Ginkgo biloba extract (EGb-761) on recovery from peripheral vestibular deafferentation (vestibular compensation)
36. Peripheral type benzodiazepine binding sites following transient forebrain ischemia in the rat: Effects of neuroprotective drugs
37. The effect of extract of Ginkgo biloba (EGb-761) on central compensation of a total unilateral peripheral vestibular deficit in the rat
38. Ginkgo biloba extract: Mechanisms and clinical indications
39. Preparation and definition of Ginkgo biloba extract
40. Antioxidant effect of a Ginkgo biloba extract (EGb-761) on the retina
41. Protective effect of EGb-761 on ischemia-reperfusion damage in the rat retina
42. Effects of ginkgolides on interleukin-1, tumour necrosis factor-a and nitric oxide production by rat microglia stimulated with lipopolysaccharides in vitro
43. Effects of repeated treatments with an extract of Ginkgo biloba (EGb-761) on cerebral glucose utilization in the rat: An autoradiographic study
44. Ginkgo biloba for dementia. A systematic review of double-blind, placebo-controlled trials
45. Effects of post-operative treatment with an extract of Ginkgo biloba (EGb-761) on vestibular compensation in the cat
46. Platelet-activating factor antagonists limit glycine changes and behavioural deficits after brain trauma
47. Evidence that Ginkgo biloba extract does not inhibit MOA A and B in living human brain
48. An investigation of the test-retest reliability of the Stroop Color-Word Test across two intervals
49. Coma in a patient with Alzheimer's disease taking low dose trazodone and Ginkgo biloba
50. Study of the long-term action of a Ginkgo biloba extract on vigilance and mental performance as determined by means of quantitative pharmaco-EEG and psychometric measurements
51. In pursuit of a retrograde messenger
52. Properties of PAF-synthesizing phosphocholinetransferase and evidence for lysoPAF acetyltransferase activity in rat brain
53. Role of Platelet-activating factor in long-term potentiation of the rat medial vestibules nuclei
54. Expression of glial fibrillary acidic protein (GFAP), glutamine synthetase (GS), and Bcl-2 protooncogene protein by Müller (glial) cells in retinal light damage of rats
55. Retinal light damage vs. normal aging of rats: Altered morphology, intermediate filament expression, and nuclear organization of Müller (glial) cells
56. Interaction of neuroprotective substances with human brain superoxide dismutase. An in vitro study
57. Clinical experience with platelet-activating factor antagonists. Past, present and near future
58. Binding of platelet-activating factor to platelets of Alzheimer's disease and multiinfarct dementia patients
59. Platelet-activating factor and cerebral vasospasm following subarachnoid hemorrhage
60. The efficacy of EGb-761 in patients with senile dementia of the Alzheimer type, a double-blind, placebo-controlled study on different levels of investigation
61. Extract of Ginkgo biloba (EGb-761) improves behavioural performance and reduces histopathology after cortical contusion in the rat
62. Closing functional expression of platelet-activating factor receptor from guinea pig lung
63. Evidence for a therapeutic effect of Ginkgo biloba special extract. Meta-analysis of 11 clinical studies in patients with cerebrovascular insufficiency in old age
64. Antagonists of platelet-activating factor: Chemistry, pharmacology and clinical applications
65. Ginkgolides and platelet-activating factor binding sites
66. A2-Adrenoceptor changes during cerebral ageing. The effect of Ginkgo biloba extract
67. Decreased cerebral 5-HT1A receptors during ageing: Reversal by Ginkgo biloba extract (EGb-761)
68. Leukotrienes in brain: Natural occurrence and induced changes
69. Platelet-activating factor: A mediator for clinicians
70. Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms
71. Natural substances in psychiatry (Ginkgo biloba in Dementia)
72. The pharmacological effects of Ginkgo biloba, a plant extract, on the brain of dementia patients in comparison with tacrine
73. Memory enhancement by intrahippocampal, intraamygdala, or intraentorhinal infusion of platelet-activating factor measured in an inhibitory avoidance task
74. Regulation and signal transduction of PAF receptor
75. Ginkgo biloba: A living fossil
76. Protection of hypoxia-induced ATP decrease in endothelial cells by Ginkgo biloba extract and bilobalide
77. Inhibitory effect of platelet-activating factor (PAF) on luteinizing hormone-releasing hormone and somatostatin release from rat median eminence in vitro correlated with the characterization of specific PAF receptor sites in rat hypothalamus
78. Proof of efficacy of the Ginkgo biloba special extract EGb-761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia
79. Effect of an extract of Ginkgo biloba on rat brain energy metabolism in hypoxia
80. Platelet-activating factor as a potential retrograde messenger in CA1 hippocampal long-term potentiation
81. The protection of the retina from ischemic injury by the free radical scavenger EGb-761 and zinc in the cat retina
82. Ginkgo biloba
83. Ginkgo biloba for cerebral insufficiency
84. Phospholipid breakdown and choline release under hypoxic conditions: Inhibition by bilobalide, a constituent of Ginkgo biloba
85. Platelet-activating factor receptor is not required for long-term potentiation in the hippocampal CA1 region
86. Ginkgo biloba extract (EGb-761): Inhibitory effect on nitric oxide production in the macrophage cell line RAW 264.7
87. Lipid peroxidation in experimental spinal cord injury
88. The therapeutic application of Ginkgo extract EGb-761 in the treatment of vascular diseases: The experimental background
89. Endogenous platelet-activating factor does not modulate blood flow and metabolism in normal rat brain
90. Platelet-activating factor (PAF). A review of its effects, antagonists and possible future clinical applications (part I)
91. PAF. A review of its effects, antagonists and possible future clinical applications (part II)
92. Platelet-activating factor antagonists: Scientific background and possible clinical applications
93. Influence of an extract of Ginkgo biloba on cerebral blood flow and metabolism
94. In vitro effect of Ginkgo biloba extract (EGb-761) on the activity of presynaptic cholinergic nerve terminals in rat hippocampus
95. Production and effects of platelet-activating factor in the rat brain
96. Platelet-activating factor stimulates arachidonic acid release and enhances thromboxane B2 production in intact fetal rat brain ex vivo
97. EEG profile of three different extractions of Ginkgo biloba
98. Plasticity mechanisms in vestibular compensation in the cat are improved by an extract of Ginkgo biloba (EGb-761)
99. Presence of specific platelet-activating factor binding sites in neuroblastoma N1E-115 cells
100. Platelet-activating factor receptor antagonism improves cerebral recovery after circulatory arrest
101. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia
102. Effects of Ginkgo biloba on changes induced by quantitative cerebral microembolization in rats
103. Experimental therapy of a platelet-activating factor antagonist (ginkgolide B) on photochemically induced thrombotic cerebral ischemia in tree shrews
104. Platelet-activating factor in stroke and brain injury
105. Ginkgolide B accelerates vestibular compensation of spontaneous ocular nystagmus in guinea pig following unilateral labyrinthectomy
106. Platelet-activating factor in the CNS
107. Peroxyl radical scavenging activity of Ginkgo biloba extract EGb-761
108. Distinct platelet-activating factor binding sites in synaptic endings and in intracellular membranes of rat cerebral cortex
109. Effect of chronic administration of Ginkgo biloba extract or ginkgolide on the hypothalamic-pituitary-adrenal axis in the rat
110. Antioxidant action of Ginkgo biloba extract EGb-761
111. The nitric oxide-scavenging properties of Ginkgo biloba extract EGb-761
112. Association of Ginkgo biloba with intracerebral hemorrhage
113. Clinical efficacy of Ginkgo biloba special extract EGb-761 in dementia of the Alzheimer type
114. Retrograde messengers, long-term potentiation and memory
115. An examination of the efficacy of Ginkgo biloba extract EGb-761 on the neuropsychologic functioning of cognitively intact older adults
116. Absorption, distribution, and excretion of tagged Ginkgo biloba leaf extract in the rat
117. Antihypertensive functions of the kidney: Arthur. C. Corcoran memorial lecture
118. Preventive effect of Ginkgo biloba extract on apoptosis in rat cerebellar neuronal cells induced by hydroxyl radicals
119. Involvement of platelet-activating factor (PAF) in glutamate neurotoxicity in rat neuronal cultures
120. The efficacy of Ginkgo biloba on cognitive function on Alzheimer's disease
121. Flow cytometric estimation of the effect of Ginkgo biloba extract on the content of hydrogen peroxide in dissociated mammalian brain neurons
122. 2+-loaded brain neurons
123. Ginkgo biloba extract protects brain neurons against oxidative stress induced by hydrogen peroxide
124. Effects of a platelet-activating antagonist (BN-52021) on free fatty acids, diacylglycerols, polyphosphoinositides and blood flow in the gerbil brain: Inhibition of ischemia-reperfusion induced cerebral injury
125. Alzheimer's Disease Assessment Scale-cognitive in clinical practice
126. Ginkgo biloba extract (EGb-761) protects Na,K-ATPase activity during cerebral ischemia in mice
127. Superoxide anion scavenging effect and superoxide dismutase activity of Ginkgo biloba extract
128. Effects of an extract of Ginkgo biloba (EGb-761) on "learned helplessness" and other models of stress in rodents
129. Evaluation of a Ginkgo biloba extract (EGb-761) in functional tests for monoamine oxidase inhibition
130. Platelet-activating factor antagonists reduce excitotoxic damage in cultured neurons from embryonic chick telencephalon and protect the rat hippocampus and neocortex from ischemic injury in vivo
131. A double-blind, placebo-controlled study of Ginkgo biloba extract ('Tanakan') in elderly out-patients with mild to moderate memory impairment
132. Prevention by a Ginkgo biloba extract (GBE 761) of the dopaminergic neurotoxicity of MPTP
133. Peroxidation of synaptosomes alters the dopamine uptake complex but spares the exocytotic release of dopamine
134. Functional protection of photoreceptors from light-induced damage by dimethylthiourea and Ginkgo biloba extract
135. Demonstration of the 'anti-stress' activity of an extract of Ginkgo biloba (EGb-761) using a discrimination learning task
136. Myc-immortalized microglial cells express a functional platelet-activating factor receptor
137. The effects of acute doses of standardized Ginkgo biloba extract on memory and psychomotor performance in volunteers
138. Decreased electroconvulsive shock-induced diacylglycerols and free fatty acid accumulation in the rat brain by Ginkgo biloba extract (EGb-761): Selective effect in hippocampus as compared with cerebral cortex
139. EGb-761 inhibits stress-induced polydipsia in rats
140. A new rating scale for Alzheimer's disease
141. Spontaneous hyphema associated with ingestion of Ginkgo biloba extract (letter)
142. Excitotoxicity and the NMDA receptor: Stice lethal after 8 years
143. Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion
144. A note on some psychometric properties of Sternberg task performance: Modifications to content
145. Taking stock of cognition enhancers
146. A Ginkgo biloba extract (EGb-761) prevents mitochondrial aging by protecting against oxidative stress
147. Evidence that the Ginkgo biloba extract, EGb-761, neither accelerates nor enhances the rapid compensation of the static symptoms of unilateral vestibular deafferentation in guinea pig
148. Validity and reliability of the Alzheimer's disease cooperative study - Clinical Global Impression of Change
149. Antioxidative activity of ginkgolides against superoxide in an aprotic environment
150. Development and validation of the Geriatric Evaluation by Relative's Rating Instrument (GERRI)
151. Focal ischemia enhances choline output and decreases acetylcholine output from the rat cerebral cortex
152. Upregulation of neuronal nitric oxide synthase, edema and cell injury following heat stress are reduced by pretreatment with EGb-761 in the rat
153. Platelet-activating factor receptor and signal transduction
154. Platelet-activating factor receptor and signal transduction mechanisms
155. Identification of kaempferol as a monoamine oxidase inhibitor and potential neuroprotectant in extract of Ginkgo biloba leaves
156. Platelet-activating factor and its analogs: Metabolic pathways and related intracellular processes
157. Acetylcholine-induced production of platelet-activating factor by human fetal brain cells in culture
158. Clinical improvement of memory and other cognitive functions by Ginkgo biloba: Review of relevant literature
159. Involvement of platelet-activating factor (PAF) in cerebral post-ischemic phase in mongolian gerbils
160. Platelet-activating factor stimulates a fos/jun/AP-1 transcriptional signaling system in human neuroblastoma cells
161. Calcium-sensitive cytosolic phospholipase A2 (cPLA2) is expressed in human brain astrocytes
162. Ginkgo biloba extract (EGb-761) independently improves changes in passive avoidance learning and brain membrane fluidity in the aging mouse
163. The psychopharmacological effects of Ginkgo biloba extract in normal healthy volunteers
164. Ischemia and reperfusion-induced histological changes in rat retina: Demonstration of a free radical mediated mechanism
165. EGb-761 and the recovery of ion imbalance in ischemic reperfused diabetic rat retina
166. Direct measurement of free radicals in ischemic/reperfused diabetic rat retina
167. 2+/ascorbate/EDTA-induced lipid peroxidation
168. Effects of posttraining intrahippocampal injections of platelet-activating factor and PAF antagonists on memory
169. A competitive receptor binding assay for platelet-activating factor (PAF): Quantification of PAF in rat brain
170. Pharmacological activity of the Ginkgo biloba extract (EGb-761) on equilibrium function recovery in the unilateral vestibular neurectomized cat
171. Transbilayer movement and metabolic fate of ether-linked phosphatidic acid (1-O-Octadecyl-2-acetyl-sn-glycerol 3-phosphat) in guinea pig peritoneal polymorpho nuclear leukocytes
172. Phytomedicines in western Europe: Their potential impact on herbal medicine in the United States
173. Subarachnoid haemorrhage-associated with Ginkgo biloba
174. Determination of ginkgolides and bilobalide in Ginkgo biloba leaves and phytopharmaceuticals
175. The efficacy of Ginkgo for elderly people with dementia and age-associated memory impairment: New results of a randomized clinical trial
176. Platelet-activating factor: A phospholipid autocoid with diverse actions
177. Efficacy of Ginkgo biloba in 90 outpatients with cerebral insufficiency caused by old age
178. Effects of Ginkgo biloba extract (EGb-761) on guinea pig medial vestibular nuclei neurons: An in vitro study
179. Ginkgo not effective for memory loss in elderly
180. Bilobalide, a constituent of Ginkgo biloba, inhibits NMDA-induced phospholipase A2 activation and phospholipid breakdown in rat hippocampus
181. Ginkgo biloba in the treatment of sexual dysfunction due to antidepressant drugs
182. Long-term potentiation in the hippocampus induced by platelet-activating factor
183. Effects of an extract of Ginkgo biloba on learning and memory in mice
184. The effects of an extract of Ginkgo biloba, EGb-761, on cognitive behavior and longevity in the rat
185. Effects of Ginkgo biloba extract on cognitive function and blood pressure in elderly subjects
186. Facilitative effect of EGb-761 on olfactory recognition in young and aged rats
187. Involvement of monoamine oxidase inhibition in neuroprotective and neurorestorative effects of Ginkgo biloba extract against MPTP-induced nigrostriatal dopaminergic toxicity in C57 mice
188. Synergistic protective effects of combined blockade by two kinds of auto lesion mediator receptor on neurological function after cervical cora injury
189. Effects of Ginkgo biloba extract (EGb-761) on the guinea pig vestibular system
190. The Ginkgo biloba extract EGb-761 rescues the PC12 neuronal cells from beta-amyloid-derived diffusible neurotoxic ligands
191. Characterization of a human cDNA that encodes a functional receptor for platelet-activating factor
192. Platelet-activating factor: A putative neuromodulator and mediator in the pathophysiology of brain injury
193. Production of platelet-activating factor from rat cerebellar granule cells in culture
194. Characterization of platelet-activating factor-induced elevation of cytosolic free-calcium level in neurohybrid NCB-20 cells
195. Modulation of ischemic signal by antagonists of N-methyl-D-aspartate, nitric oxide synthase, and platelet-activating factor in gerbil hippocampus
196. Reactive oxygen species-induced apoptosis in PC12 cells and protective effect of bilobalide
197. The effects of classic antipsychotic haloperidol plus the extract of Ginkgo biloba on superoxide dismutase in patients with chronic refractory schizophrenia
198. Oxidatively fragmented phospholipids as inflammatory mediators: The dark side of polyunsaturated lipids